Background and Format: Bioscience Today is a contemporary publication written for decision makers within the Bioscience, Medical, Pharmaceutical and Healthcare markets.

Offers technical information, thought leadership, and commentary for the biosimilar development and manufacturing community. Tracks industry trends and challenges affecting emerging biosimilar markets with articles, case studies, and white papers related to biosimilar development, manufacturing, quality, distribution, FDA guidance, BPCIA, global markets, government regulations, and intellectual property.

Launched in March 2006 and focuses on understanding the social, ethical, legal, economic, public and policy aspects of current and emerging developments in life sciences.

Impact Factor: 1.789 (Source: 2015 Journal Citation Reports, Thomson Reuters) Journal Ranking: 12/39 Social Sciences, Biomedical (Source: 2015 Journal Citation Reports, Thomson Reuters) Frequency: Published 4 times a year Aims of the journal: BioSocieties is committed to the scholarly exploration of the crucial social, ethical and policy implications of developments in the life sciences and biomedicine. The journal seeks to provide a crucial forum where the most rigorous social research and critical analysis of these issues can intersect with the work of leading scientists, social researchers, clinicians, regulators and other stakeholders. BioSocieties aims to define the key intellectual issues at the science-society interface, and offers pathways to the resolution of the critical local, national and global socio-political challenges that arise from scientific and biomedical advances. Content: The journal publishes scholarship across the social science disciplines, and represents a lively and balanced array of perspectives on controversial issues. In its inaugural year BioSocieties demonstrated the constructive potential of interdisciplinary dialogue and debate across the social and natural sciences. Articles, response pieces, book reviews, and self-standing editorial pieces by social and life scientists form a regular part of the journal.

Launched in 1995 as a business-to-business life sciences site, BioSpace's mission is to improve productivity in the process of discovery. The site is divided into 12 sections: Clinical Competitive Intelligence, featuring clinical updates and a search engine for clinical developments; Breaking News; Career Center, which posts job listings for people in life science industries; Hotbed Communities, which serves organizations and individuals involved in life science research and product development; Companies; For Investors; Start-Ups, a portion tailored for an entrepreneurial audience, providing relevant news, feature stories, updates on raised capital and personnel changes, as well as listings of start-up jobs, events, and company profiles; Science Center, which serves as a gathering point of news and information currently available on the site; Industry Events; Expert Search; Marketplace; and Resources, which includes company profiles, education, and reference services. The site strives to serve the industry as a point of convergence for information, products and services, people and capital through 11 communities in the United States, Canada, Europe and Israel. The GenePool newsletter, a daily e-mail of breaking industry news and information, is also available on the site. The content on the site is aggregated from various news wire services including PR Newswire, Businesswire and CNN.com.

Definitive source for industry trends, news and information for the biopharmaceuticals marketplace. Each themed issue covers topics ranging from product breakthroughs, industry insights, clinical trials and innovations. Sections in every issue include: Washington Report, Patient Profile, Leadership Corner, Industry Insight, BioResources and BioDashboard.

BioTalk with Rich Bendis covers biohealth. Main URL: http://www.biohealthinnovation.org/biohealth-news/biotalk-with-rich-bendis-podcast

Discusses commercial, legal, political and scientific trends in biotechnology. Posts commentary on the state of biotechnology research and how social and legal forces around the world impact how and where biotechnology is advancing. The blog can be contacted via the online form. The fundamentals of working with bloggers are the same as with traditional journalists at traditional media outlets: respect their schedules; take time to read their material to learn their interests; and only contact them if/when they want to be contacted. You will also find that if a blogger is a journalist for another outlet(s), Cision tracks their contact preferences there as well. The outlet offers RSS (Really Simple Syndication).

This companion series to Tech Nation offers more insights and interviews in the world of science, but with a sole focus on biotechnology. Bio Tech Nation does not accept faxes. The program offers RSS(Really Simple Syndication) and a digital Podcast.

The Biotech Strategy Blog provides commentary and insight on new product development in the pharma and biotech industries with a focus on oncology, hematology, immunotherapy and immuno-oncology.